Evidence map›Paper›PMID 28239655›Full record

ArticleJCI insight2017

Alterations in sarcomere function modify the hyperplastic to hypertrophic transition phase of mammalian cardiomyocyte development.

Benjamin R Nixon, Alexandra F Williams, Michael S Glennon, Alejandro E de Feria, Sara C Sebag, H Scott Baldwin, Jason R Becker

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. DNA damage and repair in cardiomyopathy: mechanisms and therapeutic opportunities.American journal of physiology. Heart and circulatory physiology · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Interaction between cardiac myosin-binding protein C and formin Fhod3.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 3 countries.

Benjamin R NixonDepartment of Medicine, Division of Cardiovascular Medicine.
Alexandra F WilliamsDepartment of Medicine, Division of Cardiovascular Medicine.
Michael S GlennonDepartment of Medicine, Division of Cardiovascular Medicine.
Alejandro E de FeriaDepartment of Medicine, Division of Cardiovascular Medicine.
Sara C SebagDepartment of Medicine, Division of Cardiovascular Medicine.
H Scott BaldwinDepartment of Pediatrics, Division of Pediatric Cardiology.
Jason R BeckerDepartment of Medicine, Division of Cardiovascular Medicine.
Cardiovascular Research Center · BRPediatrics and Genetics · US

Funding

Developmental Determinants of Cardiovascular DiseaseT32HL105334 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BALDWIN, H SCOTT · 2011 to 2021
$4.3M
Tie Tek Modulation of Cardiac DevelopmentR01HL118386 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BALDWIN, H SCOTT · 2013 to 2017
$2.1M
Training in neuromuscular diseasesT32NS077984 · NINDS · OHIO STATE UNIVERSITY · PI GUTTRIDGE, DENIS C, MENDELL, JERRY ROY · 2012 to 2016
$946k
The role of Raf-MEK signaling in the pathogenesis of hypertrophic cardiomyopathyK08HL116803 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BECKER, JASON · 2013 to 2017
$668k
NHLBI NIH HHS K08 HL116803NHLBI NIH HHS R01 HL118386NHLBI NIH HHS T32 HL105334NINDS NIH HHS T32 NS077984
6 · The paper itself

Abstract

It remains unclear how perturbations in cardiomyocyte sarcomere function alter postnatal heart development. We utilized murine models that allowed manipulation of cardiac myosin-binding protein C (MYBPC3) expression at critical stages of cardiac ontogeny to study the response of the postnatal heart to disrupted sarcomere function. We discovered that the hyperplastic to hypertrophic transition phase of mammalian heart development was altered in mice lacking MYBPC3 and this was the critical period for subsequent development of cardiomyopathy. Specifically, MYBPC3-null hearts developed evidence of increased cardiomyocyte endoreplication, which was accompanied by enhanced expression of cell cycle stimulatory cyclins and increased phosphorylation of retinoblastoma protein. Interestingly, this response was self-limited at later developmental time points by an upregulation of the cyclin-dependent kinase inhibitor p21. These results provide valuable insights into how alterations in sarcomere protein function modify postnatal heart development and highlight the potential for targeting cell cycle regulatory pathways to counteract cardiomyopathic stimuli.

Indexed as

Cell EnlargementAnimalsCardiomyopathiesCarrier ProteinsCell CycleCell ProliferationCyclin-Dependent Kinase Inhibitor p21CyclinsGene Expression Regulation, DevelopmentalHeartHyperplasiaHypertrophyMiceMyocytes, CardiacMyosin Binding Protein CPhosphorylationCarrier ProteinsCyclin-Dependent Kinase Inhibitor p21CyclinsMyosin Binding Protein CRetinoblastoma Protein

Identifiers

PMID28239655
PMCPMC5313062
OpenAlexW2588926992

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.